Displaying 21 - 30 of 506 News articles. Show 5 | 10 | 20 | 40 | 60 results per page.

Read the latest news from PraxisAuril on the world of Knowledge Exchange

USIT Guide

26 Apr 2023

The UK’s potential as a science super-power has been given a significant boost today with the launch of unique guidance that will accelerate and support the founding of a new generation of start-ups.

New Drug to Lower Brain Pressure could Treat Blinding IIH Headaches

27 Mar 2023

Trials to lower brain pressure in patients with type2 diabetes also reduced the number of 'blinding' headaches

Naturally Occurring Peptide may Tackle the ‘Root Cause’ of Obesity-Related Conditions

9 Mar 2023

Research published today by the University of Birmingham, shows that a peptide (small protein) called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases such as hepatic steatosis (fatty liver). 

200 Jobs Boost as Global Defence and Security Firm Chooses Newcastle for New Research Site

20 Feb 2023

Proximity to Newcastle University and National Innovation Centre for Data key to Leonardo announcement .

Novel Adaptation for Existing Furnaces could Reduce CO2 Emissions from Steelmaking by 90%

24 Jan 2023

Researchers from University of Birmingham, U.K., show novel adaptation for existing furnaces could reduce steelmaking emissions by 90%

PraxisAuril Announces New Chief Executive

7 Dec 2022

PraxisAuril is delighted to announce the appointment of David Russell as its new CEO.

And the winners are…

28 Nov 2022

PraxisAuril is delighted to announce the winners of the 2022 KE Awards

ChromaTwist Lands Second Round of Equity Funding to Develop Fluorescent Dyes for the Flow Cytometry Market

14 Nov 2022

University of Birmingham spinout ChromaTwist Ltd has secured £487k of equity investment to develop its new class of fluorescent dyes for the flow cytometry reagent market.

PrA welcomes two new Board members

10 Nov 2022

PraxisAuril is delighted to announce that two new Directors have been appointed to the PraxisAuril Board, both for four-year terms.

Busting the myths surrounding UK university spinouts

9 Nov 2022

PraxisAuril is delighted to share the release of a new technical report from the University Commercialisation and Innovation Policy Evidence Unit (UCI) headed up by Tomas Coates Ulrichsen and based at the University of Cambridge. The report marks a significant step forward in our shared understanding of current practice in taking equity in university spinouts in the UK. Thank you to all the PraxisAuril members who took the time to speak to the UCI team about your spinout policies, typical practice and experience with the wide variety of stakeholders involved.